Chris Wood is a Chief Investment Officer for Healthcare and Biotech at Mauldin Economics, as well as a Chief Investment Officer at RiskHedge, a professional investment research firm focused on understanding and profiting from disruption. With over 16 years of professional experience as a professional investor, author, and tech commentator, Chris is considered as a Health and Biotech Market veteran and one of America’s most respected analysts. Throughout his career, his unique ability to consistently pinpoint stocks that double and triple has intrigued thousands of readers. In addition to his corporate responsibilities, Chris also speaks in investment conferences and evaluates investments on the road.
2008 - 2018